全文获取类型
收费全文 | 988篇 |
免费 | 69篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 45篇 |
妇产科学 | 15篇 |
基础医学 | 149篇 |
口腔科学 | 33篇 |
临床医学 | 57篇 |
内科学 | 231篇 |
皮肤病学 | 16篇 |
神经病学 | 35篇 |
特种医学 | 68篇 |
外科学 | 126篇 |
综合类 | 113篇 |
预防医学 | 33篇 |
眼科学 | 9篇 |
药学 | 57篇 |
1篇 | |
中国医学 | 5篇 |
肿瘤学 | 68篇 |
出版年
2023年 | 9篇 |
2022年 | 7篇 |
2021年 | 20篇 |
2020年 | 16篇 |
2019年 | 22篇 |
2018年 | 15篇 |
2017年 | 20篇 |
2016年 | 21篇 |
2015年 | 33篇 |
2014年 | 38篇 |
2013年 | 37篇 |
2012年 | 52篇 |
2011年 | 42篇 |
2010年 | 39篇 |
2009年 | 32篇 |
2008年 | 38篇 |
2007年 | 34篇 |
2006年 | 28篇 |
2005年 | 27篇 |
2004年 | 24篇 |
2003年 | 23篇 |
2002年 | 22篇 |
2001年 | 29篇 |
2000年 | 23篇 |
1999年 | 23篇 |
1998年 | 29篇 |
1997年 | 25篇 |
1996年 | 31篇 |
1995年 | 19篇 |
1994年 | 25篇 |
1993年 | 15篇 |
1992年 | 8篇 |
1991年 | 8篇 |
1990年 | 18篇 |
1989年 | 12篇 |
1988年 | 22篇 |
1987年 | 16篇 |
1986年 | 9篇 |
1985年 | 20篇 |
1984年 | 10篇 |
1983年 | 11篇 |
1979年 | 8篇 |
1977年 | 9篇 |
1976年 | 8篇 |
1974年 | 6篇 |
1973年 | 11篇 |
1972年 | 11篇 |
1971年 | 13篇 |
1970年 | 10篇 |
1969年 | 6篇 |
排序方式: 共有1063条查询结果,搜索用时 15 毫秒
1.
2.
Golli M; Van Nhieu JT; Mathieu D; Zafrani ES; Cherqui D; Dhumeaux D; Vasile N; Rahmouni A 《Radiology》1994,190(3):741
3.
4.
5.
6.
7.
Inhibition of 2-nitropropane-induced rat liver DNA and RNA damage by benzyl selenocyanate 总被引:5,自引:2,他引:3
We observed that pretreatment of male F344 rats with benzyl selenocyanate,
a versatile organoselenium chemopreventive agent in several animal model
systems, decreases the levels of DNA and RNA modifications produced in the
liver by the hepatocarcinogen 2- nitropropane. To clarify the mechanisms
involved, we pretreated male F344 rats with either benzyl selenocyanate,
its sulfur analog benzyl thiocyanate, phenobarbital or cobalt
protoporphyrin IX; the latter is a depletor of P450. We then determined (1)
the ability of liver microsomes to denitrify 2-nitropropane, (2) effects on
2-nitropropane- induced liver DNA and RNA modifications and (3) amount of
nitrate excreted in rat urine following administration of the carcinogen.
Pretreatment with benzyl selenocyanate or phenobarbital increased the
denitrification activity of liver microsomes by 217 and 765%, respectively,
increased liver P4502B1 by 31- and 435-fold, respectively, decreased the
levels of 2-nitropropane-induced modifications in liver DNA (29-70% and
17-30%, respectively) and RNA (67-85% and 30-50%, respectively), and
increased the 24-h urinary excretion of nitrate by 157 and 209%,
respectively. Pretreatment with benzyl thiocyanate had no significant
effect on any of these parameters. Pretreatment with cobalt protoporphyrin
IX decreased liver P4502B 1 by 87%, decreased the denitrification activity
of liver microsomes by 76%, decreased the 24 h urinary excretion of nitrate
by 88.5%, but increased the extent of 2-nitropropane-induced liver nucleic
acid modifications by 17-67%. These results indicate that the metabolic
sequence from 2-nitropropane to the reactive species causing DNA and RNA
modifications does not involve the removal of the nitro group. Moreover,
they suggest that benzyl selenocyanate inhibits 2-NP-induced liver nucleic
acid modifications in part by increasing its detoxication through induction
of denitrification, although it is evident that other mechanisms must also
be involved.
相似文献
8.
9.
10.
Squamous cell carcinoma antigen as an adjunct tumour marker in primary carcinoma of the lung. 总被引:1,自引:0,他引:1
下载免费PDF全文
![点击此处可从《Journal of clinical pathology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
AIMS--To determine (1) the detection rate of primary carcinoma of the lung by serological assay of CEA (carcinoembryonic antigen); and (2) whether addition of seroassay of squamous cell carcinoma related antigen before treatment improves detection sensitivity. METHODS--A prospective study spanning 27 months was conducted at the University Hospital, Kuala Lumpur. Serum CEA (Abbott IMx) and serum squamous cell carcinoma antigen (Abbott IMx) from patients clinically suspected of having primary carcinoma of the lung, were assayed using the microparticle enzyme immunoassay method. RESULTS--Thirty seven cases of histologically confirmed primary lung carcinoma were studied. Of these, 17 were squamous cell carcinomas, 10 adenocarcinomas, nine small cell carcinomas, and one large cell carcinoma. The patients' ages ranged from 34-82 years. The male:female ratio was 3.6:1. Squamous cell carcinoma antigen was raised above the cutoff value of 1.5 ng/ml in 94.1% of squamous cell carcinomas, 20.0% of adenocarcinomas, and 11.1% of small cell carcinomas. By comparison, CEA was raised above the cutoff value of 3.0 ng/ml in 70.6% of squamous cell carcinomas, 77.8% of small cell carcinomas, and 100% of adenocarcinomas. CEA and squamous cell carcinoma antigen were not raised in the patient with large cell carcinoma and in 14 healthy volunteers. None of 15 patients with a variety of benign lung diseases showed a rise of CEA, while two patients--a 25 year old Indian woman with pneumonia and a 64 year old Malay man with bronchial asthma--had raised squamous cell carcinoma antigen values above the cutoff. Serum CEA and squamous cell carcinoma antigen values did not seem to correlate with stage or degree of differentiation of the tumours. CONCLUSIONS--The findings suggest that CEA is a good general marker for carcinoma, particularly adenocarcinoma. In contrast, squamous cell carcinoma antigen is more specific for squamous carcinoma. 相似文献